Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126924641 | 12692464 | 1 | I | 201006 | 20160815 | 20160829 | 20160829 | EXP | CA-CIPLA LTD.-2016CA17600 | CIPLA | NACCARATO M, YOONG D, GOUGH K. A POTENTIAL DRUG-HERBAL INTERACTION BETWEEN GINKGO BILOBA AND EFAVIRENZ. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PHYSICIANS IN AIDS CARE. 2012;11 (2):98 TO 100 | 0.00 | Y | 0.00000 | 20160829 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126924641 | 12692464 | 1 | PS | Efavirenz | EFAVIRENZ | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 2 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 3 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 4 | I | Ginkgo biloba | GINKGO | 1 | Unknown | 300 MG, PER DAY | U | 0 | 300 | MG | |||||||
| 126924641 | 12692464 | 5 | SS | Horse chestnut | HORSE CHESTNUT | 1 | Unknown | UNK, ONCE OR TWICE MONTHLY | U | 0 | |||||||||
| 126924641 | 12692464 | 6 | C | Omega-3 fatty acid | OMEGA-3 FATTY ACIDS | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 7 | C | Calcium | CALCIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 8 | C | Magnesium | MAGNESIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 10 | C | Multivitamin | VITAMINS | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126924641 | 12692464 | 11 | C | Flax oil | 2 | Unknown | UNK | U | U | 0 | |||||||||
| 126924641 | 12692464 | 12 | C | Rutin | RUTIN | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126924641 | 12692464 | 1 | HIV infection |
| 126924641 | 12692464 | 2 | HIV infection |
| 126924641 | 12692464 | 3 | HIV infection |
| 126924641 | 12692464 | 5 | Haemorrhoids |
| 126924641 | 12692464 | 6 | Supplementation therapy |
| 126924641 | 12692464 | 7 | Supplementation therapy |
| 126924641 | 12692464 | 8 | Supplementation therapy |
| 126924641 | 12692464 | 9 | Supplementation therapy |
| 126924641 | 12692464 | 10 | Supplementation therapy |
| 126924641 | 12692464 | 11 | Supplementation therapy |
| 126924641 | 12692464 | 12 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126924641 | 12692464 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126924641 | 12692464 | Drug interaction | |
| 126924641 | 12692464 | Virologic failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |